With $30M funder, Durham firm plans expansion

With $30 million of new funding in the bank, Ribometrix plans to double its team, find real estate for a new office and begin developing drug candidates.   This week, the Durham-based biotech company announced $30 million in Series A funding, led by M Ventures, and including new investing companies such as Amgen Ventures, Pappas Capital and Illumina Ventures.  CEO Mike Solomon said the funding will take the company out of its current Durham locat ion, where it has been working through Biolabs since…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news